These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8634718)
1. Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase. Vorechovský I; Luo L; de Saint Basile G; Hammarström L; Webster AD; Smith CI Hum Mol Genet; 1995 Dec; 4(12):2403-5. PubMed ID: 8634718 [No Abstract] [Full Text] [Related]
2. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families. Zhu Q; Zhang M; Winkelstein J; Chen SH; Ochs HD Hum Mol Genet; 1994 Oct; 3(10):1899-900. PubMed ID: 7849721 [No Abstract] [Full Text] [Related]
3. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia. Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269 [TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018 [TBL] [Abstract][Full Text] [Related]
5. Point mutation in intron 11 of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. Shinomiya N; Kanegane H; Watanabe A; Yamaguchi Y; Futatani T; Miyawaki T Pediatr Int; 2000 Dec; 42(6):689-92. PubMed ID: 11192530 [No Abstract] [Full Text] [Related]
6. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697 [TBL] [Abstract][Full Text] [Related]
7. A new point mutation involving a highly conserved leucine in the Btk SH2 domain in a family with X linked agammaglobulinaemia. Ohashi Y; Tsuchiya S; Konno T J Med Genet; 1995 Jan; 32(1):77-8. PubMed ID: 7897635 [No Abstract] [Full Text] [Related]
8. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. Saffran DC; Parolini O; Fitch-Hilgenberg ME; Rawlings DJ; Afar DE; Witte ON; Conley ME N Engl J Med; 1994 May; 330(21):1488-91. PubMed ID: 8164701 [No Abstract] [Full Text] [Related]
9. SSCP at the BTK locus. Vorechovský I Hum Mol Genet; 1994 Jun; 3(6):1031. PubMed ID: 7951224 [No Abstract] [Full Text] [Related]
10. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804 [TBL] [Abstract][Full Text] [Related]
11. Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot. Gaspar HB; Bradley LA; Katz F; Lovering RC; Roifman CM; Morgan G; Levinsky RJ; Kinnon C Hum Mol Genet; 1995 Apr; 4(4):755-7. PubMed ID: 7633429 [No Abstract] [Full Text] [Related]
12. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia. Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734 [TBL] [Abstract][Full Text] [Related]
13. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia. Schuster V; Seidenspinner S; Kreth HW Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128 [TBL] [Abstract][Full Text] [Related]
14. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype. Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386 [TBL] [Abstract][Full Text] [Related]
15. X-linked agammaglobulinemia and Bruton's tyrosine kinase. Tsukada S; Witte ON Adv Exp Med Biol; 1994; 365():233-8. PubMed ID: 7887309 [No Abstract] [Full Text] [Related]
16. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia. Hagemann TL; Chen Y; Rosen FS; Kwan SP Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320 [TBL] [Abstract][Full Text] [Related]
17. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238 [TBL] [Abstract][Full Text] [Related]
18. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900 [TBL] [Abstract][Full Text] [Related]
19. Missense mutations affecting a conserved cysteine pair in the TH domain of Btk. Vihinen M; Nore BF; Mattsson PT; Bäckesjö CM; Nars M; Koutaniemi S; Watanabe C; Lester T; Jones A; Ochs HD; Smith CI FEBS Lett; 1997 Aug; 413(2):205-10. PubMed ID: 9280283 [TBL] [Abstract][Full Text] [Related]
20. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA). Staehelin F; Kühne T Clin Lab Haematol; 2000 Apr; 22(2):123-5. PubMed ID: 10792406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]